Insulet Corp. (PODD)
$148.06-1.75-1.17%Nov 10
Loading chart…
M.Cap$10.3B
Dividends—
Next report—
Forecast
Target
P/E23.5
P/S3.19
P/B6.50
5-y avg sales growth+24.5%
Debt / EBITDA2.06
ROE16.3%
Altman Z-score9.08 (safe)
RSI56
MFI70
Price / MA50+4.3% (med) ↓
Trend pattern
Financial Statements
No data available
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
About

Insulet Corporation creates and sells insulin delivery systems for those with insulin-dependent diabetes. Their main product is the Omnipod System, a device worn on the body for three days at a time, along with a handheld personal diabetes manager. They sell their products through distributors, pharmacies, and directly in various countries worldwide.

https://www.insulet.com
Beta 1.06